BOPA Introduction to Oncology Course Research Published

The BOPA Introduction to Oncology Course Improves Knowledge of Oncology Pharmacy Professionals.

 

A peer-reviewed article has been published on the Journal of Oncology Pharmacy Practice (JOPP) showing that there are overall knowledge gain for Oncology Pharmacy Professionals after attending BOPA’s Introduction to Oncology course.

‘This study has demonstrated that overall the ITO course improved the baseline knowledge of the delegates attending the course in November 2023 (+1.21). The delegates were also more confident in verifying SACT prescriptions after the course.’

Cracknell N, Parbutt C, Wong C, Ganijee T. A study to quantify knowledge obtained during the British Oncology Pharmacy Association (BOPA) Introduction to Oncology (ITO) Course. Journal of Oncology Pharmacy Practice. 2024;0(0). doi:10.1177/10781552241259367 (Complementary assess of this article is available to ISOPP members, join no-fee ISOPP now.)

Well done and congratulations to BOPA members and ITO Chairs, Netty Cracknell fBOPA, Catherine Parbutt mBOPA, Clayton Wong mBOPA and Tasneem Ganijee mBOPA on the publication.


#BOPAITO returns to London on 4th and 5th November 2024. Registration information will be announced soon, interested delegates are advised to seek study leave approval from their employers prior to registration.

Latest News

By UK SACT Board on 9th November 2026

New UK SACT Board National Intrathecal and Intraventricular SACT Guidance

Dear colleagues, We are pleased to share the newly published UK SACT Board National Guidance on the Safe Administration of Systemic Anti-Cancer Therapies via the Intrathecal or Intraventricular Routes. This…

Read article
By BOPA Executive Committee on 9th November 2026

BOPA members flying the flag for cancer pharmacy at ESMO 2026

It was fantastic to see BOPA members representing cancer pharmacy at ESMO Congress 2026 in Madrid, which brought together the global cancer community from 23 to 27 October to share…

Read article
By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article